companydata.dkcompanydata.dk

BACH BOLIGCENTER ApS: Financial statements 2025

CVR: 12024584

Source: annual report 2025, Danish Business Authority

01/04/2024 – 31/03/2025

BACH BOLIGCENTER ApS (CVR 12024584) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -20,454 and a net result of DKK -35,885 compared with DKK 38,084 the year before. Equity in the 2025 report amounted to DKK 306,664. The solvency ratio was 94.5%. The company had 1 employee in the financial year.

Gross Profit
DKK -20,454
Profit/Loss
DKK -35,885
Equity
DKK 306,664
Total Assets
DKK 324,492
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--20K-36K307K1
2024--20K38K404K1
2023--15K-201K424K1
2022--14K-153K682K1
2021--13K-9K892K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BACH BOLIGCENTER ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About BACH BOLIGCENTER ApS

BACH BOLIGCENTER ApS is a Danish company of the type Anpartsselskab based in Hammel, founded in 1988. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named EMBRYODAN ApS. The management consists of Geo Koch. The company is owned by Geo Koch. The company has 1 employee (2023). In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122.

Source: annual report 2026, Danish Business Authority